A nine-herb traditional Chinese formula reduced gut graft-vs.-host disease severity and suppressed FGF2/PI3K/Akt signaling in a mouse model, according to a new study combining network pharmacology and ...
A 2026 Review argues that osteosarcoma survival and lung spread depend on stage-specific rewiring of extracellular-matrix ...
A natural compound extracted from a medicinal plant has shown surprising promise against rheumatoid arthritis. In rats, it ...
These data lend support for Faeth’s multi-node strategy, with two upcoming readouts: FTH-PIK-201 topline data in second-line advanced endometrial cancer by year-end 2026 and FTH-PIK-101 interim data ...
Scientists co-led by St. Jude Children's Research Hospital have identified a potential therapeutic vulnerability in some ...
Combining EP300 degradation with AKT inhibition slowed osteosarcoma growth and prolonged survival in preclinical mouse models ...
BridgeBio Oncology's total equity value of $226 million is lower than its liquid assets of $344.1 million as of June 30. See ...
VIKTORIA-1 shows gedatolisib maintained strong PFS benefit over alpelisib in PIK3CA-mutant HR+/HER2− breast cancer, including ...
Faeth Therapeutics announced presentation of preclinical data at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain, in a poster entitled ?Characterising the efficacy of ...
The Oct. 23 poster covers PIKTOR alone and with fulvestrant, oral SERDs and CDK inhibitors; data are intended to inform the ongoing FTH-PIK-101 Phase 1b/2 trial.
The herbal compound helped reduce joint swelling and cartilage damage in rats with experimental arthritis. Scientists have ...
Published data validates ZIP12-mediated zinc signaling as a novel driver of pulmonary vascular remodeling and supports a differentiated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results